1. Introduction {#s0005}
===============

The dried roots and leaves of *Isatis indigotica* Fort. (Cruciferae), having names of "ban lan gen" and "da qing ye", respectively, are used in traditional Chinese medicine for the treatment of various diseases. They are among the most common ingredients of formulations used for treating influenza, cold, and fever[@bib1]. Chemical and pharmacological studies demonstrated that extracts of these drug materials contained diverse chemical constituents with various biological activities[@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24]. Although the drug materials are practically utilized by decocting with water, only few chemical studies on the water decoctions were previously reported[@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24]. Because the constituents of extracts are highly dependent upon extraction methods, we consider that there must be unknown bioactive chemical constituents in the decoctions. Therefore, the water decoction of the *I. indigotica* roots was investigated as part of a program to assess the chemical and biological diversity of traditional Chinese medicines[@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44], [@bib45], [@bib46], [@bib47]. This has led to discovery of many new chemical constituents with diverse structural types and biological activities from "ban lan gen"[@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib53], [@bib54], [@bib55], [@bib56], [@bib57], [@bib58], [@bib59], [@bib60], [@bib61]. A continuation on the same decoction has resulted in structure characterization of nine new sulfur-containing natural products (**1**−**5**, **6a**, **6b**, **7a**, and **7b** [Fig. 1](#f0005){ref-type="fig"}). Among them, **1**--**5** possess unusual sulfur-enriched structures, biogenetically associated with the co-occurring epigoitrin (**8a**, [Fig. 1](#f0005){ref-type="fig"}). The enantiomers **6a** and **6b** are diastereomers of **9a** and **9b** ([Fig. 1](#f0005){ref-type="fig"}) possessing the unique indolin-2-one, dihydrothiopyran, and 1,2,4-thiadiazole ring system previously reported from the same extract[@bib49] and recently synthesized *via* a rare thio-Diels--Alder reaction[@bib62]. Herein, we report isolation, structure elucidation, and proposed biosynthetic relationship of the new isolates, along with antiviral activities of **2** and **4**.Figure 1The structures of compounds **1**--**9**.Fig. 1

2. Results and discussion {#s0010}
=========================

Compound **1**, a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +38.8 (*c* 0.1, MeCN), showed IR absorptions attributable to amino (3208 cm^--1^), carbonyl (1702 cm^--1^), and thiocarbonyl (1542 cm^--1^) functionalities. Its molecular formula was determined as C~20~H~26~N~4~NaO~4~S~3~ by HR-ESI-MS and NMR spectroscopic data. The ^1^H NMR spectrum of **1** showed partially overlapping resonances attributable to a pair of exchangeable amino protons at *δ*~H~ 9.57 and 9.62 (each 1H, brs); a pair of disubstituted double bonds at *δ*~H~ 5.71 and 5.70 (each 1H, t, *J* = 5.0 Hz, H-2′ and H-3′) and 5.59 and 5.58 (each 1H, t, *J* = 6.0 Hz, H-2′′′ and H-3′′′); and a pair of terminal double bonds at *δ*~H~ 5.53 (2H, d, *J* = 17.5 Hz, H-7a/7′′a), 5.42 (2H, d, *J* = 10.0 Hz, H-7b/7′′b), 6.10 and 6.09 (each 1H, ddd, *J* = 17.5, 10.0, and 8.0 Hz, H-6 and H-6′′). In addition, the spectrum displayed partially overlapping resonances assignable to a pair of heteroatom-bearing methines at *δ*~H~ 5.34 (2H, dt, *J* = 10.0 and 8.0 Hz, H-5/5′′) and three pairs of heteroatom-bearing methylenes at *δ*~H~ 4.47 (2H, t, *J* = 10.0 Hz, H-4a/4′′a), 4.02 and 4.01 (1H each, dd, *J* = 10.0 and 8.0 Hz, H-4b and H-4′′b); 3.98 (2H, t, *J* = 6.0 Hz, H~2~-4′′′) and 3.94 (2H, t, *J* = 5.0 Hz, H~2~-4′); 3.23 (2H, d, *J* = 6.0 Hz, H~2~-1′′′) and 3.14 (2H, d, *J* = 5.0 Hz, H~2~-1′). The ^13^C NMR and DEPT spectra exhibited partially overlapping carbon signals corresponding to the above units as well as those due to two pairs of quaternary carbons at *δ*~C~ 186.4 (C-2/2′′) and 152.0 (C-5′/5′′′). Especially differences of the chemical shifts for most of the pairing signals were less than Δ*δ*~C~ ±0.1. As compared with those of the reported compounds from this plant[@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib53], [@bib54], [@bib55], [@bib56], [@bib57], [@bib58], [@bib59], [@bib60], [@bib61], these spectroscopic data suggested that **1** was an unusual asymmetric dimer of alkaloid containing three sulfur atoms, of which the structure was further elucidated by 2D NMR data analysis.

The proton and proton-bearing carbon resonances in the NMR spectra were assigned by the HSQC experiment of **1**. In the ^1^H--^1^H COSY spectrum, the vicinal coupling cross-peaks of H~2~-4/H-5/H-6/H~2~-7 (H~2~-4′′/H-5′′/H-6′′/H~2~-7′′) and the HMBC correlations from H~2~-4 to C-2, C-5, and C-6 (H~2~-4′′ to C-2′′, C-5′′, and C-6′′) ([Fig. 2](#f0010){ref-type="fig"}), in combination with comparison of the chemical shifts of these proton and carbon signals with those of the co-occurring epigoitrin (**8a**), revealed the presence of a pair of *N*- and *N*′′-substituted epigoitrin units in **1**. In addition, the ^1^H--^1^H COSY cross-peaks of H~2~-1′/H-2′/H-3′/H~2~-4′/N′*H* and H~2~-1′′′/H-2′′′/H-3′′′/H~2~-4′′′/N′′′*H*, together with the HMBC correlations from H~2~-1′ to C-1′′′ and from H~2~-1′′′ to C-1′ as well as their chemical shifts, indicated that there were a pair of *N*′- and *N*′′′-substituted 4′-amino-but-2′-enyl and 4′′′-amino-but-2′′′-enyl units, connecting each other *via* a thioether bond between C-1′ and C-1′′′. Moreover, the HMBC spectrum of **1** exhibited the correlations from both H~2~-4′ and H~2~-4′′′ to the carbon resonance at *δ*~C~ 152.0 (C-5′ and C-5′′′). This demonstrated that the amino groups of the sulfur-bridged bis-butenamine moiety must connect *via* C-5′ and C-5′′′ with the two epigoitrin units to match requirement of the molecular formula and *N*- and *N*′′-substitution, though no three-bond correlations from H~2~-4 and/or H~2~-4′′ to C-5′ and C-5′′′ were observed in the HMBC spectrum. Accordingly, the planar structure of **1** was determined as shown.Figure 2Main ^1^H--^1^H COSY (thick lines) and three-bond HMBC (arrows, from ^1^H to ^13^C) correlations of compounds **1**−**7**.Fig. 2

The ROESY spectrum of **1** displayed the NOE correlations between H~2~-1′′′ and H~2~-4′′′ as well as between H~2~-1′ and H-3′ and between H-2′ and H~2~-4′ ([Fig. 3](#f0015){ref-type="fig"}), suggesting a 2′-*trans*-2′′′-*cis* geometric configuration for **1**. The suggestion was supported by the chemical shift rule for the *α*-alkyl carbons connecting to the *trans*- and *cis*-double bonds (*δ*~*trans*~\>*δ*~*cis*~),[@bib63] because the chemical shift values of C-1′ and C-4′ (*δ*~C~ 32.9 and 42.2) were larger than those of C-1′′′ and C-4′′′ (*δ*~C~ 27.5 and 37.9) in **1**. The specific rotation value of **1** was almost doubled as compared with that of **8a**, ${\lbrack\alpha\rbrack}_{D}^{20}$ +21.6 (*c* 2.4, CHCl~3~), suggesting that the absolute configuration at C-5 and C-5′′ in **1** are identical to that in **8a**. This was further supported by comparison of the experimental CD and calculated ECD spectra of **1** ([Fig. 4](#f0020){ref-type="fig"}). Therefore, the structure of compound **1** was determined and named isatithioetherin A.Figure 3ROESY/NOESY correlations (double arrows between protons) of compounds **1**--**5**.Fig. 3Figure 4The overlaid experimental CD (full lines) and calculated ECD spectra (dash lines) of compounds **1**--**3**.Figure 4

Compound **2**, a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +32.0 (*c* 1.7, MeCN), showed similar spectroscopic data to those of **1**, except that the NMR spectra of **2** displayed only half the number of resonances corresponding to the proton and carbon atoms expected from the molecular formula. This suggested that **2** was an isomer of **1** with the symmetric structure, which was supported by EI-MS data of **2** at *m/z* (%) 129 (100) and 225 (22) arising from cleavage of the carbamide and thioether bonds, respectively ([Supplementary Information Fig. S30](#s0085){ref-type="sec"}). Comparison of the spectroscopic NMR data between **2** and **1** ([Table 1](#t0005){ref-type="table"}) demonstrated that the 2′′′-*cis* double bond in **1** was absent in **2**. Thus, **2** was assigned as the 2′′′-*trans* isomer of **1**, which was proved by 2D NMR data analysis, especially by the HMBC correlation from H~2~-1′ to C-1′′′ (H~2~-1′′′ to C-1′) and the NOESY correlations between H~2~-1′ and H-3′ (H~2~-1′′′ and H-3′′′) and H-2′ and H~2~-4′ (H-2′′′ and H~2~-4′′′) ([Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}) as well as the chemical shifts of C-1′ and C-4′ (C-1′′′ and C-4′′′). The similarity of specific rotation and CD data between **2** and **1** indicated that the two compounds had the same absolute configuration, which was supported by comparison of the experimental CD and calculated ECD spectra of **2** ([Fig. 4](#f0020){ref-type="fig"}). Thus, the structure of compound **2** was determined and named isatithioetherin B.Table 1NMR spectroscopic data for compounds **1**−**5**[a](#tbl1fna){ref-type="table-fn"}.Table 1**12345**No.*δ*~H~*δ*~C~*δ*~H~*δ*~C~*δ*~H~*δ*~C~*δ*~H~*δ*~C~*δ*~H~*δ*~C~2186.4186.4186.4186.3186.44a4.47 t (10.0)52.54.47 dd (11.0, 9.0)52.54.47 dd (11.0, 9.0)52.54.47 dd (11.0, 9.0)52.54.47 dd (11.0, 9.0)52.54b4.02 dd (10.0, 8.0)4.00 dd (11.0, 8.0)4.00 dd (11.0, 8.0)4.00 dd (11.0, 8.0)4.00 dd (11.0, 8.0)55.34 dt (10.0, 8.0)80.35.35 dt (9.0, 8.0)80.35.35 dt (9.0, 8.0)80.35.35 dt (9.0, 8.0)80.25.35 dt (9.0, 8.0)80.366.10 ddd (17.5, 10.0, 8.0)134.56.09 ddd (17.5, 10.5, 8.0)134.56.09 ddd (17.5, 10.5, 8.0)134.56.08 ddd (17.0, 10.5, 8.0)134.56.08 ddd (17.0, 10.5, 8.0)134.57a5.53 d (17.5)121.05.53 d (17.5)121.05.53 d (17.5)121.05.53 d (17.0)121.05.53 d (17.0)121.07b5.42 d (10.0)5.43 d (10.5)5.42 d (10.5)5.42 d (10.5)5.42 d (10.5)1′a3.14 d (5.0)32.93.11 d (6.0)32.33.37 d (6.0)41.33.58 d (5.5)40.93.74 dt (12.0, 7.0)43.61′b3.14 d (5.0)3.11 d (6.0)3.37 d (6.0)3.58 d (5.5)3.57 dt (12.0, 7.0)2′5.70 t (5.0)129.65.65 t (6.0)129.65.73 t (6.0)128.15.79 t (5.5)127.43.68 q (7.0)53.53′5.71 t (5.0)129.55.65 t (6.0)129.55.73 t (6.0)130.95.79 t (5.5)131.55.76 ddd (17.0, 10.5, 7.0)136.24′a3.94 t (5.0)42.23.93 t (6.0)42.23.96 t (6.0)42.23.98 t (5.5)42.25.30 d (17.0)119.34′b3.94 t (5.0)3.93 t (6.0)3.96 t (6.0)3.98 d (5.5)5.23 d (10.5)5′152.0151.7151.7151.7152.02′′186.4186.4186.4186.3186.34′′a4.47 t (10.0)52.54.47 dd (11.0, 9.0)52.54.47 dd (11.0, 9.0)52.54.47 dd (11.0, 9.0)52.54.47 dd (11.0, 9.0)52.54′′b4.01 dd (10.0, 8.0)4.00 dd (11.0, 8.0)4.00 dd (11.0, 8.0)4.00 dd (11.0, 8.0)4.00 dd (11.0, 8.0)5′′5.34 dt (10.0, 8.0)80.35.35 dt (9.0, 8.0)80.35.35 dt (9.0, 8.0)80.35.35 dt (9.0, 8.0)80.25.35 dt (9.0, 8.0)80.36′′6.09 ddd (17.5, 10.0, 8.0)134.56.09 ddd (17.5, 10.5, 8.0)134.56.09 ddd (17.5, 10.5, 8.0)134.56.08 ddd (17.0, 10.5, 8.0)134.56.08 ddd (17.0, 10.5, 8.0)134.57′′a5.53 d (17.5)121.05.53 d (17.5)121.05.53 d (17.5)121.05.53 d (17.0)121.05.53 d (17.0)121.07′′b5.42 d (10.0)5.43 d (10.5)5.42 d (10.5)5.42 d (10.5)5.42 d (10.5)1′′′3.23 d (6.0)27.53.11 d (6.0)32.33.37 d (6.0)41.33.58 d (5.5)40.93.42 d (5.0)41.82′′′5.58 t (6.0)128.65.65 t (6.0)129.65.73 t (6.0)128.15.79 t (5.5)127.45.74 t (5.0)127.93′′′5.59 t (6.0)130.25.65 t (6.0)129.55.73 t (6.0)130.95.79 t (5.5)131.55.74 t (5.0)131.24′′′3.98 t (6.0)37.93.93 t (6.0)42.23.96 t (6.0)42.23.98 t (5.5)42.23.97 t (5.0)42.25′′′152.0151.7151.7151.7151.8N′H9.57 brs9.61 brs9.64 brs9.64 brs9.72 brsN′′′H9.62 brs9.61 brs9.64 brs9.64 brs9.64 brs[^1]

Compound **3** was obtained as a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +30.4 (*c* 0.2, MeCN). Its molecular formula C~20~H~26~N~4~O~4~S~4~ with one more sulfur atom than **1** and **2** was determined by HR-ESI-MS and NMR spectroscopic data. The UV, IR, and NMR spectroscopic features of **3** resembled those of **2**. However, as compared the NMR spectroscopic data between **3** and **2** ([Table 1](#t0005){ref-type="table"}), the chemical shifts of H~2~-1′(H~2~-1′′′) and C-1′(C-1′′′) in **3** were significantly deshielded by Δ*δ*~H~ +0.26 and Δ*δ*~C~ +9.0, respectively. This suggested replacement of the sulfide bond in **2** by a disulfide bond in **3**, which was verified by the 2D NMR data analysis ([Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}), particularly by the absence of the correlation from H~2~-1′ to C-1′′′ (H~2~-1′′′ to C-1′) in the HMBC spectrum of **3**. The presence of the disulfide bond was further proved by EI-MS data of **3** at *m/z* (%) 129 (100), 225 (7), and 256 (29) due to breakdown of the carbamide, carbon-sulfur, and disulfide bonds, respectively ([Supplementary Information Fig. S51](#s0085){ref-type="sec"}). The 5 *R*,5′′*R*-configuration of **3** was supported by the specific rotation and CD data as well as by comparison of the experimental CD and calculated ECD spectra of **3** ([Fig. 4](#f0020){ref-type="fig"}). Therefore, the structure of compound **3** was determined and named isatithioetherin C.

Compound **4** was obtained as a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +28.0 (*c* 0.47, MeCN). The molecular formula of **4** was determined as C~20~H~26~N~4~O~4~S~5~ with one more sulfur atom than that of **3** (Experimental [Section 4.3](#s0035){ref-type="sec"} and [Table 1](#t0005){ref-type="table"}). In addition, comparing the NMR spectroscopic data between the two compounds ([Table 1](#t0005){ref-type="table"}), the chemical shifts of H~2~-1′, H-2′, and H-3′ (H~2~-1′′′, H-2′′′, and H-3′′′) in **4** were changed by Δ*δ*~H~ +0.21, +0.06, and +0.06 respectively. These differences revealed that **4** was the trisulfide derivative of **3**, which was also proved by 2D NMR data analysis of **4** ([Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}). Especially, the EI-MS data of **3** with successive losses of two sulfur atoms at *m/z* (%) 320 (6), 288 (23), and 256 (8) ([Supplementary Information Fig. S66](#s0085){ref-type="sec"}), further confirmed a liner linkage of the three sulfur atoms in **4**. Consistency of the specific rotation and CD data as well as the calculated ECD spectra of **4** and **3** ([Figs. 4](#f0020){ref-type="fig"} and [5](#f0025){ref-type="fig"}) indicated that stereochemistry of the two compounds was identical. Thus, the structure of compound **4** was determined and named isatithioetherin D.

Compound **5**, a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +39.2 (*c* 0.21, MeCN), is an isomer of **3** as indicated by spectroscopic data (Experimental [Section 4.3](#s0035){ref-type="sec"} and [Table 1](#t0005){ref-type="table"}). However, the NMR spectroscopic data showed that **5** had an asymmetric structure. Comparison of the NMR spectroscopic data between **5** and **3** ([Table 1](#t0005){ref-type="table"}) demonstrated that a terminal double bond \[*δ*~H~ 5.76 (1H, ddd, *J* = 17.0, 10.5, and 7.0 Hz, H-3′), 5.30 (1H, d, *J* = 17.0 Hz, H-4′a), and 5.23 (1H, d, *J* = 10.5 Hz, H-4′b); and *δ*~C~ 136.2 (C-3′) and 119.3 (C-4′)\] and a sulfur-bearing methine \[*δ*~H~ 3.68 (1 H, q, *J* = 7.0 Hz, H-2′) and *δ*~C~ 53.5 (C-2′)\] in **5** replaced one *trans*-disubstituted double bond and one sulfur-bearing methylene in **3**. In addition, the resonances for one nitrogen-bearing methylene changed from *δ*~H~ 3.96 (2H, t, *J* = 6.0 Hz, H~2~-4′) and *δ*~C~ 42.2 (C-4′) in **3** to *δ*~H~ 3.74 and 3.57 (1H each, dt *J* = 12.0 and 7.0 Hz, H-1′a and H-1′b) and *δ*~C~ 43.6 (C-1′) in **5**. This demonstrated replacement of the 4′-amino-but-2′-enyl unit in **3** by an 1′-amino-but-3′-en-2′-yl unit in **5**. The deduction was proved by the ^1^H--^1^H COSY cross peaks of N*H*/H~2~-1′/H-2′/H-3′/H~2~-4′, the HMBC correlations from H~2~-1′ to C-5′, and the ROESY correlations between H~2~-1′′′ and H-3′′′ and between H-2′′′ and H~2~-4′′′ ([Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}). The chemical shifts of H~2~-2′, H~2~-2′′′ and C-2′ and C-2′′′, together with the molecular composition, demonstrated that a 1′′′,2′-disulfide bond must be formed in **5**, which was further supported by EI-MS data ([Supplementary Information Fig. S82](#s0085){ref-type="sec"}). Similarity of the specific rotation and CD data between **5** and **3** suggested that they had the same 5 *R*,5′′*R*-configuration. Especially, the experimental CD spectrum of **5** matched well with the calculated ECD spectrum ([Fig. 5](#f0025){ref-type="fig"}), but significantly differed from that of the 2′-epimer of **5** ([Supplementary Information Figs. S10 and S12](#s0085){ref-type="sec"}). This supported that **5** had the 2′*S*,5*R* ′′*R*-configuration. Therefore, the structure of compound **5** was determined and named isatithioetherin E.Figure 5The overlaid experimental CD (full lines) and calculated ECD spectra (dash lines) of compounds **4**, **5**, and (2′*R*)-**5**.Fig. 5

Compound **6** was obtained as a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +15.2 (*c* 0.24, MeOH). Its spectroscopic data were similar to those of the scalemic mixture of **9a** and **9b** in a 2:1 ratio from the same decoction[@bib49] \[herein, given trivial names (−)-isatithiopyrin A for **9a** and (+)-isatithiopyrin A for **9b**, respectively\]. However, TLC and reversed-phase HPLC analysis indicated that **6** was different from **9**. Comparison of the NMR spectroscopic data between **6** ([Table 2](#t0010){ref-type="table"}) and **9** in the same solvent DMSO-*d*~6~[@bib49] demonstrated that H-1′′′a and 2′′′-O*H* in **6** were shielded by Δ*δ*~H~ −0.05 and −0.10, respectively, whereas H-1′′′b, H-2′′′, H-3′′′, H-4′′′a, and H-4′′′b were deshielded by Δ*δ*~H~ +0.05, +0.06, +0.16, +0.23, and +0.12, while differences of the chemical shifts for the other proton resonances and all the carbon resonances were less than Δ*δ*~H~ ±0.03 and Δ*δ*~C~ ±0.3. Based on these changes and the optical activity, **6** was deduced as either a diastereomer of **9a** and **9b** or a scalemic mixture of the diastereomers of **9a** and **9b**, which was further confirmed by 2D NMR data analysis of **6** in both the solvents of acetone-*d*~6~ and DMSO-*d*~6~ ([Fig. 2](#f0010){ref-type="fig"}). Because the specific rotation data of **6** was opposite to that of **9** with almost an equal magnitude and because the later was proved as the scalemic mixture of **9a** and **9b** in a 2:1 ratio[@bib49], **6** must be a mixture containing two enantiomers in the same 2:1 ratio. Although subsequent chiral HPLC separation proved the presence of two partially resolved peaks with an integration of about 2:1 ratio in the chromatogram of **6** ([Supplementary Information Figs. S113 and S114](#s0085){ref-type="sec"}), further isolation of the two components failed due to decomposition of the sample in solid state storing at 10 °C for 6 months. Since two chiral centers exist in the structures, there are only four stereoisomers including two pairs of enantiomers. With the previous chiral separation and structural assignment of **9a** and **9b** as the (−)-(2′′′*S*,3*S*)- and (+)-(2′′′*R*,3*R*)-enantiomers[@bib49], [@bib62], respectively, **6** must be a mixture consisting of (2′′′*S*,3*R*)- and (2′′′*R*,3 *S*)-enantiomers in the approximate 2:1 or 1:2 ratio and the optical properties of **6** must be from the exceed enantiomer. The experimental spectrum of **6** was in good agreement with the theoretically calculated ECD spectrum of the (2′′′*S*,3*R*)-enantiomer (**6a**, [Fig. 6](#f0030){ref-type="fig"}), whereas mirrored to that of the (2′′′*R*,3*S*)-enantiomer (**6b**) ([Supplementary Information Fig. S14](#s0085){ref-type="sec"}). This supported that **6** consisted of **6a** and **6b** in the approximate 2:1 ratio and that the positive specific rotation of **6** was from the exceed **6a**. Accordingly, **6b** must has the negative specific rotation. Therefore, the structures of compounds **6a** and **6b** were assigned and named as (+)-and (−)-isatithiopyrin B, respectively. It is worth noting that the four stereoisomers were very recently synthesized by a biomimetic thio-Diels--Alder reaction, a very rare reaction in nature, and that the presence of **6a** and **6b** in the 2:1 ratio was also predicted by density functional theory (DFT) calculations[@bib62]. Therefore, compounds **6a** and **6b** are new natural products, which were chemically synthesized and theoretically predicted.Table 2NMR spectroscopic data for compounds **6** and **7**[a](#tbl2fna){ref-type="table-fn"}.Table 2**6** (DMSO-*d*~6~)**6** (Acetone-*d*~6~)**7** (MeOH-*d*~4~)No.*δ*~H~*δ*~C~*δ*~H~*δ*~C~*δ*~H~*δ*~C~2176.7177.6177.2348.449.53a128.9130.34a7.04 brd (7.2)124.37.07 dd (7.2, 0.6)125.33.67 dd (10.2, 7.2)50.04a3.33 dd (10.2, 7.2)56.91 ddd (7.8, 7.2, 0.6)122.06.91 ddd (7.8, 7.2, 0.6)122.94.46 dt (7.8, 7.2)50.567.27 ddd (7.8, 7.8, 0.6)129.87.26 ddd (7.8, 7.2, 0.6)130.55.94 ddd (17.4, 10.2, 7.8)137.27a6.93 brd (7.8)110.17.01 brd (7.2)110.95.26 d (17.4)118.07b142.7143.75.10 d (10.2)3′126.6128.54′7.42 dd (5.4, 3.0)141.37.42 dd (4.8, 4.2)142.05′a2.79 m26.62.83 m27.85′b2.79 m2.83 m6′a3.56 ddd (15.6, 10.8, 4.8)21.13.75 ddd (13.2, 8.4, 6.6)22.26′b2.77 m2.74 ddd (13.2, 4.2, 3.6)3′′173.0174.25′′185.4187.21′′′a2.81 dd (13.8, 7.2)40.52.85 dd (14.4, 5.4)41.41′′′b2.75 dd (13.8, 6.6)2.82 dd (14.4, 7.2)2′′′4.23 ddd (7.2, 6.6, 5.4)70.04.37 dt (7.2, 5.4)71.33′′′5.63 ddd (16.8, 10.8, 5.4)140.95.70 ddd (16.8, 10.8, 5.4)141.54′′′a5.02 dt (16.8, 1.8)113.75.10 dt (16.8, 1.8)114.14′′′b4.89 dt (10.8, 1.8)4.90 dt (10.8, 1.8)1-NH10.74 s9.69 s2′′′-OH4.83 d (5.4)3.68 d (5.4)[^2]Figure 6The experimental CD spectra of **6** (10 times reduced) and **7** (full lines) overlaid with the calculated ECD spectra of compounds **6a** (10 times reduced) and **7a** (dash lines).Fig. 6

Compound **7** was obtained as a colorless gum with ${\lbrack\alpha\rbrack}_{D}^{20}$ +26.3 (*c* 0.1, MeOH). Its spectroscopic features was similar to those of **8** (the scalemic mixture of **8a** and **8b** in the 2:1 ratio[@bib64]), indicating that **7** was either an isomer of **8a** and **8b** or a scalemic mixture of the isomers of **8a** and **8b**. As compared with those of **8**, the H-5 and C-5 resonances in the NMR spectra of **7** were significantly shielded by Δ*δ*~H~ −0.90 and Δ*δ*~C~ −30.0, respectively, while the C-2 resonance was shielded by Δ*δ*~C~ −10.0. The differences indicated isomerization of the oxazolidine-2-thione ring in **8** into a thiazolidin-2-one ring in **7,** which was proved by 2D NMR data analysis of **7** ([Fig. 2](#f0010){ref-type="fig"}). HPLC analysis using a chiral column (CD-ph) confirmed that **7** was a scalemic mixture of the enantiomers **7a** and **7b** in the 2:1 ratio ([Supplementary Information Fig. S126](#s0085){ref-type="sec"}). Although further preparative separation of the enantiomers failed due to decomposition of the sample in solid state during storage, similarity of the specific rotation and CD curve between **7** with **8** and **8a** indicated that the exceed enantiomer in **7** had the same configuration as **8a**. This was further supported by comparing the experimental CD spectrum of **7** with the theoretically calculated spectra of **7a** and **7b** ([Fig. 6](#f0030){ref-type="fig"}). Therefore, the structure of **7a** and **7b** were determined and named as isoepigoitrin and isogoitrin, respectively.

Compounds **1**−**5** are the first example of natural products with dimeric structure features likely deriving from epigoitrin (**8a**). Based on our previous speculations, these sulfur-containing metabolites are biosynthesized ([Scheme 1](#f0035){ref-type="fig"}) from the precursors glucosinolates[@bib49], [@bib55] including epiprogoitrin (**10**) and/or progoitrin (**11**) also, which are abundant in the 2:1 ratio of **10**:**11** in *I. indigotica*[@bib64]. Myrosinases catalyzed hydrolysis of epiprogoitrin (**10**) and progoitrin (**11**) liberates intermediate **12**, which undergoes the Lossen rearrangement, either *via* a direct process or *via* imidothioate **13**, to yield isothiocyanate **14**. An intermolecular nucleophilic addition of **14** produces **8**[@bib65]. Isolation of **7** indicates the possible presence of enzyme-catalyzed hydrolysis and dehydration processes of **14** *via* an unstable intermediate **15** to generate both **7** and **8**, because the proportion and configuration of the exceed enantiomers in the scalemic mixtures are sustained. In a stereoselective manner, an enzyme-catalyzed nucleophilic intermolecular addition between the *R*-isomers of **8** and **14** would give the optically active intermediate **16**. A further intramolecular addition of **16** generates an intermediate **17**, which undergoes migration of the thiol group to the terminal double-bond with simultaneous double bond rearrangement and breakdown of the oxygen-bridge to afford the thiol carbamides **18** and **19** (geometric isomers). The thiol group in **17** would also be migrated to the oxygen-bridged methine carbon to afford the thiol carbamide **20**, accompanying with reversion of the C-2′ configuration from 2′*R* in **17** to 2′*S* in **20**. Condensation between **18** and **19** and between two molecules of **19** produces **1** and **2**, respectively. Meanwhile, a molecule of H~2~S would be simultaneously liberated as a sulfur donor to form the disulfide **3** and trisulfide **4** from **19** as well as to form disulfide **5** from **19** and **20**. Moreover, together with **9a** and **9b**[@bib49], the isolation and structure determination of **6a** and **6b** confirmed biosynthetic formation of the stereoisomers *via* a rare thio-Diels--Alder reaction in nature[@bib62]. The experimental data demonstrate that the configuration at the spiro carbon (C-3) plays a decisive role in the specific rotations and the CD spectroscopic features of **6a**, **6b**, **9a**, and **9b**. The biogenetic speculations fully support the structural assignments of **1**--**9**.Scheme 1Proposed biosynthetic pathways of compounds **1**--**5**, **7**, and **8**.Scheme 1

Although the postulated biosynthetic precursors occur as the stereoisomers epiprogoitrin (**10**) and progoitrin (**11**) in the inequivalent amounts (2:1), **1**--**5** were obtained as the optically pure forms and their diastereomers were not founded in the decoction. The fact indicates that **1**--**5** are biosynthesized in a stereoselective manner, implying the presence of specific enzyme(s) to control the stereoselectivity. Additionally, the precursors glucosinolates can thermally be decomposed into diverse bioactive breakdown products[@bib65]. Therefore, influences of the decocting process on the bioactive components as well as the pharmacological effects of the ban lan gen decoction deserves further investigation in future studies.

In the preliminary *in vitro* assays, compounds **2** and **4** showed antiviral activity against influenza virus A/Hanfang/359/95 (H3N2)[@bib66], with IC~50~ values of 0.60 and 1.92 μmol/L and SI values of 9.62 and 3.61, respectively (the positive control RBV, IC~50~ = 0.97 μmol/L and SI = 1200). These two compounds also exhibited activity against the herpes simplex virus 1 (HSV-1)[@bib66] with IC~50~ values of 3.70 and 2.87 μmol/L and SI values of 5.20 and 2.68, respectively (the positive control acyclovir, IC~50~ = 0.71 μmol/L and SI = 140.9). In addition, **2** inhibited Coxsackie virus B3 replication[@bib66], with IC~50~ and SI values of 0.71 μmol/L and 9.04 (the positive control Pleconaril, IC~50~ = 0.41 μmol/L and SI = 243.9; RBV, IC~50~ = 222.22 μmol/L and SI = 9.0). Moreover, **2** and **4** reduced d,l-galactosamine (GAlN)-induced hepatocyte (WB-F344 cell) damage[@bib67] with 70% and 73% inhibition at 10 μmol/L, respectively, while the positive control bicyclol gave 66% inhibition.

3. Conclusions {#s0015}
==============

From the aqueous extract of the *I. indigotica* root, five novel sulfur-enriched alkaloids isatithioetherins A−E (**1**−**5**), together with two pairs of scalemic enantiomers (+)- and (−)-isatithiopyrin B (**6a** and **6b**) and isoepigoitrin and isogoitrin **(7a** and **7b**) were isolated and structurally determined. Compounds **1**--**5** represent the first examples of sulfur-enriched natural products biogenetically assembled by four epigoitrin-derived units, while **6a** and **6b** having the unique structural feature are the scalemic mixture (2:1), which were biomimetically synthesized by the rare thio-Diels--Alder reaction and theoretically predicted by the DFT calculations[@bib62]. The relatively broad antiviral spectra of **2** and **4** demonstrate that the sulfur-enriched metabolites are potentially active constituents responsible for the treatment of influenza and other diseases in clinic application of the ban lan gen decoction, though other compounds were not assayed due to limitation of the sample amounts and/or decomposition of the compounds during storage. The labile properties of the novel sulfur-enriched compounds indicate that the decocting procedure must be an important factor to significantly influence on content and composition of the chemical constituents in the ban lan gen extracts. Therefore, the extracting process must be taken into consideration in research and evaluation of ban lan gen and da qing ye. This consideration would also be valid for some of the other herbal medicines. Additionally, our previous and present results[@bib48], [@bib49], [@bib50], [@bib51], [@bib52], [@bib53], [@bib54], [@bib55], [@bib56], [@bib57], [@bib58], [@bib59], [@bib60], [@bib61] reveal that, in the ban lan gen decoction there are diverse active components against different types of viruses and continuously provide novel candidate for further studies of synthetic/biosynthetic and medicinal chemistry as well as pharmacology.

4. Experimental {#s0020}
===============

4.1. General experimental procedures {#s0025}
------------------------------------

Optical rotations were measured on a P-2000 polarimeter (JASCO, Tokyo, Japan). UV spectra were acquired on a V-650 spectrometer (JASCO, Tokyo, Japan). CD spectra were measured on a JASCO J-815 CD spectrometer (JASCO, Tokyo, Japan). IR spectra were obtained on a Nicolet 5700 FT-IR microscope instrument (FT-IR microscope transmission, Thermo Electron Corporation, Madison, WI, USA). NMR spectra were recorded at 600 or 500 MHz for ^1^H NMR and 150 or 125 MHz for ^13^C NMR, respectively, on a SYS 600 instrument (Varian Associates Inc., Palo Alto, CA, USA) or Bruker 500 NMR (Bruker Corp. Karlsruhe, Germany) spectrometer in DMSO-*d*~6~, acetone-*d*~6~ or MeOH-*d*~4~ with TMS or solvent peaks used as references. EI-MS data were measured on an AutoSpec Ultima-TOF spectrometer (Micromass, UK). ESI-MS and HR-ESI-MS data were taken on an Agilent 1100 Series LC-MSD-Trap-SL and an Agilent 6520 Accurate-Mass Q-TOF LCMS spectrometers (Agilent Technologies, Ltd., Santa Clara, CA, USA), respectively. Column chromatography (CC) was carried out on macroporous adsorbent resin (HPD-110, Cangzhou Bon Absorber Technology Co., Ltd., Cangzhou, China), CHP 20 P (Mitsubishi Chemical Inc., Tokyo, Japan), silica gel (200--300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), Sephadex LH-20 (Pharmacia Biotech AB, Uppsala, Sweden), or reversed phase C-18 silica gel (W. R. Grace & Co., Maryland, USA). HPLC separation was performed on an instrument equipped with an Agilent ChemStation for LC system, an Agilent 1200 pump, and an Agilent 1100 single-wavelength absorbance detector (Agilent Technologies, Ltd.) using a Grace semipreparative column (250 mm × 10 mm i.d.) packed with C18 reversed phase silica gel (5 μm) (W. R. Grace & Co., Maryland, USA), an analytical CD-Ph column (250 mm × 4.6 mm, Shiseido China Co., Ltd., Shanghai, China) column, or a semipreparative Chiralpak AD-H or Chiralpak IC column (250 mm × 10 mm, Daicel Chiral Technologies Co.). TLC was carried out on glass precoated silica gel GF~254~ plates (Qingdao Marine Chemical Inc.). Spots were visualized under UV light or by spraying with 7% H~2~SO~4~ in 95% EtOH followed by heating. Unless otherwise noted, all chemicals were purchased from commercially available sources and were used without further purification.

4.2. Plant material {#s0030}
-------------------

The *I. indigotica* roots (ban lan gen) were collected in December 2009 from Bozhou, Anhui Province, China. Plant identity was verified by Mr. Lin Ma (Institute of Materia Medica, Beijing, China). A voucher specimen (No. ID-S-2385) was deposited at the herbarium of Natural Medicinal Chemistry, Institute of Materia Medica.

4.3. Extraction and isolation {#s0035}
-----------------------------

The air-dried and pulvarized plant material (50 kg) was decocated with H~2~O (150 L, 3 × 1 h). The aqueous extracts were combined and evaporated under reduced pressure to yield a dark-brown residue (32 kg). The residue was dissolved in H~2~O (122L), loaded on a macroporous adsorbent resin (HPD-110, 19 kg) column (200 cm × 20 cm), and eluted successively with H~2~O (50 L), 50% EtOH (125 L), and 95% EtOH (100 L) to yield three corresponding fractions A, B and C. After removing the solvent under reduced pressure, fraction B (0.9 kg) was separated by column chromatography (CC) over MCI gel CHP 20P (5 L), with successive elution using H~2~O (10 L), 30% EtOH (30 L), 50% EtOH (20 L), 95% EtOH (10 L), and Me~2~CO (8 L), to give fractions B1--B5. Fraction B2 (547 g) was subjected to CC over silica gel, with elution by a gradient of increasing MeOH concentration (0--100%) in EtOAc and then with 30% EtOH, to yield fractions B2-1--B2-5 based on TLC analysis. Fraction B2-1 (16.3 g) was chromatographed over Sephadex LH-20 with elution by a petroleum ether/chloroform/methanol (5:5:1) mixture to yield B2-1-1--B2-1-10. Fraction B2-1-1 (2.5 g) was separated by silica gel CC (CHCl~3~/Me~2~CO, 100:1) to give B2-1-1-1--B2-1-1-6. Subsequent separation of B2-1-1-3 (54.3 mg) by reversed-phase (RP) HPLC (63% CH~3~CN in H~2~O) gave **4** (15.2 mg) and **5** (2.3 mg). Fraction B2-1-1-4 (120.1 mg) was chromatographed over Sephadex LH-20 (CHCl~3~/MeOH, 1:1) to give fractions B2-1-1-4-1 and B2-1-1-4-2, of which B2-1-1-4-1 (34.2 mg) was purified by preparative TLC (mobile phase: CHCl~3~/Me~2~CO, 15:1) to yield **1** (2.6 mg), and B2-1-1-4-2 by RP HPLC (63% CH~3~CN in H~2~O) to afford **2** (18.7 mg). Fraction B2-1-1-6 (122.7 mg) was separated by RP flash CC (0--100% MeOH in H~2~O) to give **3** (8.2 mg). B2-1-2 (600 mg) was fractionated by RP flash CC with a gradient of increasing MeOH concentration (0--100%) in H~2~O to yield B2-1-2-1--B2-1-2-4. Separation of B2-1-2-4 (10.7 mg) by RP HPLC (60% MeOH in H~2~O) afforded **6** (1.9 mg) and **9** (2.1 mg). Chiral HPLC analysis of **6** using AD-H column (250 mm × 10 mm) and mobile phase iPrOH--*n*-hexane (1:4, 2.0 mL/min) showed two peaks (**6a** and **6b**) with an approximate integration ratio of 2:1. B2-1-3 (7.6 g) was fractioned by silica gel CC (CHCl~3~/MeOH, 50:1) to give B2-1-3-1−B2-1-3-3, of which B2-1-3-1 (5 g) was chromatographed over silica gel CC (petroleum ether/Me~2~CO, 10:1) to yield **8** (3.5 g). Subsequent separation of **8** (20 mg) by HPLC using Chiralpak IC column (250 mm×10 mm) and mobile phase iPrOH--*n*-hexane mixture (1:6, 2 mL/min) yielded **8a** (12.2 mg) and **8b** (6.1 mg). B2-1-3-2 (30.5 mg) was isolated by RP HPLC (27% MeOH in H~2~O) to obtain **7** (2.5 mg). Chiral HPLC analysis of **7** using CD-ph column (250 mm×4.6 mm) and gradient elution increasing MeCN in H~2~O (20:80--65:35 in 12.0 min, 1.5 mL/min) showed two peaks (**7a** and **7b**) with an approximate integration ratio of 2:1.

### 4.3.1. Isatithioetherin A (**1**) {#s0040}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +38.8 (*c* 0.1, MeCN); UV (MeOH) *λ*~max~ (log*ε*) 258 (4.53) nm; CD (MeCN) 204 (Δ*ε*+2.90), 242 (Δ*ε*+0.29), 273 (Δ*ε* −0.24), 301 (Δ*ε* −0.54) nm; IR *ν*~max~ 3338, 3208, 3040, 2919, 1702, 1542, 1477, 1403, 1350, 1233, 1200, 1094, 1047, 966, 859, 803, 753, 721, 651, 595 cm^−1^; ^1^H NMR (acetone-*d*~6~, 500 MHz) data [Table 1](#t0005){ref-type="table"}; ^13^C NMR (acetone-*d*~6~, 125 MHz) data [Table 1](#t0005){ref-type="table"}; (+)-ESI-MS *m/z* 505 \[M + Na\]^+^, 521 \[M + K\]^+^; (−)-ESI-MS *m/z* 517 \[M+Cl\]^−^; (+)-HR-ESI-MS *m/z* 483.1206 \[M+H\]^+^ (Calcd. for C~20~H~27~N~4~O~4~S~3~, 483.1189), 505.1017 \[M+Na\]^+^ (Calcd. for C~20~H~26~N~4~O~4~S~3~Na, 505.1008).

### 4.3.2. Isatithioetherin B (**2**) {#s0045}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +32.0 (*c* 1.7, MeCN); UV (MeOH) *λ*~max~ (log*ε*) 257 (4.50) nm; CD (MeCN) 216 (Δ*ε* +4.02), 254 (Δ*ε* +0.34), 293 (Δ*ε* −0.75), 309 (Δ*ε* −0.81) nm; IR *ν*~max~ 3210, 3042, 2916, 1703, 1541, 1477, 1403, 1350, 1233, 1196, 1094, 1045, 967, 858, 810, 753, 651, 594 cm^−1^; ^1^H NMR (acetone-*d*~6~, 500 MHz) data [Table 1](#t0005){ref-type="table"}; ^13^C NMR (acetone-*d*~6~, 125 MHz) data [Table 1](#t0005){ref-type="table"}; EI-MS *m/z* (%) 225 (22), 149 (13), 129 (100), 95 (63), 85 (45), 68 (61); (+)-ESI-MS *m/z* 505 \[M + Na\]^+^, 521 \[M + K\]^+^; (−)-ESI-MS *m/z* 517 \[M + Cl\]^−^; (+)-HR-ESI-MS *m/z* 483.1204 \[M + H\]^+^ (Calcd. for C~20~H~27~N~4~O~4~S~3~, 483.1189), 505.1019 \[M + Na\]^+^ (Calcd. for C~20~H~26~N~4~O~4~S~3~Na, 505.1008).

### 4.3.3. Isatithioetherin C (**3**) {#s0050}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +30.4 (*c* 0.2, MeCN); UV (MeOH) *λ*~max~ (log*ε*) 257 (4.48) nm; CD (MeCN) 215 (Δ*ε* +1.28), 305 (Δ*ε* −0.49) nm; IR *ν*~max~ 3336, 3211, 3032, 2922, 1702, 1541, 1477, 1403, 1352, 1233, 1196, 1044, 950, 858, 753, 651, 590 cm^−1^; ^1^H NMR (acetone-*d*~6~, 500 MHz) data [Table 1](#t0005){ref-type="table"}; and ^13^C NMR (acetone-*d*~6~, 125 MHz) data [Table 1](#t0005){ref-type="table"}; EI-MS *m/z* (%) 256 (29), 225 (7), 149 (25), 129 (100), 118 (32), 96 (62), 85 (29), 69 (87); (+)-ESI-MS *m/z* 515 \[M + H\]^+^, 537 \[M + Na\]^+^; (−)-ESI-MS *m/z* 549 \[M + Cl\]^−^; (+)-HR-ESI-MS *m/z* 515.0918 \[M + H\]^+^ (Calcd. for C~20~H~27~N~4~O~4~S~4~, 515.0910), 537.0736 \[M + Na\]^+^ (Calcd. for C~20~H~26~N~4~O~4~S~4~Na, 537.0729).

### 4.3.4. Isatithioetherin D (**4**) {#s0055}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +28.0 (*c* 0.47, MeCN); UV (MeOH) *λ*~max~ (log*ε*) 258 (4.40) nm; CD (MeCN) 218 (Δ*ε* +3.53), 255 (Δ*ε* +0.24), 291 (Δ*ε* −0.80), 312 (Δ*ε* −0.79) nm; IR *ν*~max~ 3207, 3040, 2917, 1702, 1540, 1477, 1403, 1349, 1232, 1196, 1168, 1094, 1046, 965, 859, 812, 752, 650, 594 cm^−1^; ^1^H NMR (acetone-*d*~6~, 500 MHz) data [Table 1](#t0005){ref-type="table"}; ^13^C NMR (acetone-*d*~6~, 125 MHz) data [Table 1](#t0005){ref-type="table"}; EI-MS *m/z* (%) 320 (6), 288 (23), 256 (8), 225 (12), 129 (100), 118 (11), 96 (23), 85 (32), 68 (52); (+)-ESI-MS *m/z* 569 \[M+Na\]^+^; (+)-HR-ESI-MS *m/z* 547.0639 \[M+H\]^+^ (Calcd. for C~20~H~27~N~4~O~4~S~5~, 547.0630), 569.0452 \[M+Na\]^+^ (Calcd. for C~20~H~26~N~4~O~4~S~5~Na, 569.0450).

### 4.3.5. Isatithioetherin E (**5**) {#s0060}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +39.2 (*c* 0.21, MeCN); UV (MeOH) *λ*~max~ (log*ε*) 258 (4.56) nm; CD (MeCN) 208 (Δ*ε* +6.37), 261 (Δ*ε* +0.38), 292 (Δ*ε* −0.78), 314 (Δ*ε* −0.83) nm; IR *ν*~max~ 3204, 3050, 2921, 2855, 1702, 1541, 1477, 1402, 1350, 1232, 1196, 1095, 1046, 965, 948, 859, 808, 753, 651, 593 cm^−1^; ^1^H NMR (acetone-*d*~6~, 500 MHz) data [Table 1](#t0005){ref-type="table"}; ^13^C NMR (acetone-*d*~6~, 125 MHz) data [Table 1](#t0005){ref-type="table"}; EI-MS *m/z* (%) 320 (3), 288 (18), 256 (6), 223 (5), 129 (100), 118 (12), 96 (26), 85 (34), 68 (54); (+)-ESI-MS *m/z* 537 \[M + Na\]^+^, 553 \[M + K\]^+^; (−)-ESI-MS *m/z* 549 \[M + Cl\]^−^; (+)-HR-ESI-MS *m/z* 515.0916 \[M + H\]^+^ (Calcd. for C~20~H~27~N~4~O~4~S~4~, 515.0910); 537.0732 \[M + Na\]^+^ (Calcd. for C~20~H~26~N~4~O~4~S~4~Na, 537.0729).

### 4.3.6. (+)- and (−)-isatithiopyrin B (**6a** and **6b**) in a 2:1 ratio {#s0065}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +15.2 (*c* 0.24, MeOH); UV (MeOH) *λ*~max~ (log*ε*) 209 (4.37), 250 (sh, 3.56) nm; CD (MeCN) 231 (Δ*ε* −3.61), 259 (Δ*ε* +2.87), 284 (Δ*ε* +1.10) nm; IR *ν*~max~ 3255, 3089, 3026, 2924, 2852, 1716, 1619, 1474, 1413, 1321, 1243, 1184, 1135, 1107, 1077, 1027, 997, 929, 835, 753, 721, 690, 633, 564, 492 cm^−1^; ^1^H NMR (acetone-*d*~6~, 600 MHz) data [Table 2](#t0010){ref-type="table"}, ^1^H NMR (DMSO-*d*~6~, 600 MHz) data [Table 2](#t0010){ref-type="table"}, ^13^C NMR (acetone-*d*~6~, 150 MHz) data [Table 2](#t0010){ref-type="table"}, ^13^C NMR (DMSO-*d*~6~, 150 MHz) data [Table 2](#t0010){ref-type="table"}; (+)-ESI-MS *m/z* 372 \[M + H\]^+^, 394 \[M + Na\]^+^, 410 \[M + K\]^+^; (−)-ESI-MS *m/z* 406 \[M + Cl\]^−^; (+)-HR-ESI-MS *m/z* 372.0849 \[M + H\]^+^ (Calcd. 372.0835 for C~18~H~18~N~3~O~2~S~2~), 394.0667 \[M + Na\]^+^ (Calcd. 394.0654 for C~18~H~17~N~3~O~2~S~2~Na).

### 4.3.7. Isoepigoitrin and Isogoitrin (**7a** and **7b**) in a 2:1 ratio {#s0070}

Colorless gum; ${\lbrack\alpha\rbrack}_{D}^{20}$ +26.3 (*c* 0.1, MeOH); UV (MeOH) *λ*~max~ (logε) 207 (4.12), 250 (sh, 1.22) nm; CD (MeCN) 233 (Δ*ε* +0.08), 287 (Δ*ε* −0.04), 339 (Δ*ε* −0.02) nm; IR (KBr) *ν*~max~ 3245, 3087, 2982, 2879, 1679, 1539, 1473, 1420, 1355, 1296, 1245, 1214, 1138, 1070, 989, 969, 930, 799, 723, 677, 614 cm^−1^; ^1^H NMR (MeOH-*d*~4~, 600 MHz) data [Table 2](#t0010){ref-type="table"}; ^13^C NMR (MeOH-*d*~4~, 150 MHz) data [Table 2](#t0010){ref-type="table"}; EI-MS *m/z* (%) 129 \[M\]^·+^ (63), 96 (27), 85 (64), 73 (100), 71 (61), 69 (90), 57 (40); (+)-HR-ESI-MS *m/z* 130.0320 \[M+H\]^+^ (Calcd. for C~5~H~8~NOS, 130.0321), 152.0136 \[M+H\]^+^ (Calcd. for C~5~H~8~NOSNa, 152.0141).

### 4.3.8. ECD calculations of **1**--**5**, **6a**/**6b**, and **7a**/**7b** {#s0075}

For details, see [Supplementary Information](#s0085){ref-type="sec"}. Briefly, conformational analysis and quantum computations were performed using Gaussian 16 program package. The lowest energy conformers whose relative energy within 4 kcal/mol were further optimized at the B3LYP/6--31 g(d,p) level. The energies, oscillator strengths, and rotational strengths were calculated using the TDDFT methodology at the CAM-B3LYP/6--311+G (d,p) level. Conductor-like polarizable continuum model (CPCM) was adopted to consider solvent effects using the dielectric constant of MeCN (*ε* = 35.7) for **1**---**5** and **7** and MeOH (*ε* = 32.6) for **6**.

Appendix A. Supplementary material {#s0085}
==================================
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[^1]: Data (*δ*) were measured in acetone-*d*~6~ for **1**-**5** at 500 MHz for ^1^H NMR and 125 MHz for ^13^C NMR. Coupling constants (*J*) in Hz are given in parentheses. The assignments were based on DEPT, ^1^H--^1^H COSY, HSQC and HMBC experiments.

[^2]: Data (*δ*) were measured at 600 MHz for ^1^H NMR and 150 MHz for ^13^C NMR. Coupling constants (*J*) in Hz are given in parentheses. The assignments were based on DEPT, ^1^H--^1^H COSY, HSQC and HMBC experiments.
